R and D
News
ExonHit and BioMérieux end colon cancer collaboration – 10-Mar-2010
The partners say the clinical data did not reach the required level of performance.
Cellzome signs second inflammatory disease alliance with GSK – 10-Mar-2010
The collaboration will exploit Cellzome's proteomics technology in epigenetics.
Abbott to acquire Facet Biotech – 10-Mar-2010
The deal provides a promising biologic to treat multiple sclerosis.
BT Pharma becomes Genticel and secures €13m in funding – 9-Mar-2010
Genticel will focus its efforts on the prevention of cervical cancer in HPV infected women.
Nano particles carry drugs to diseased cells – 9-Mar-2010
Researchers grow empty particles derived from a plant virus and make them carry useful chemicals.
Technical
Reshaping water for greater solubility – 9-Feb-2010
Regina Nadborny, head of chemistry at Do-Coop Technologies, explains how water can be manipulated at a molecular level to help solubilise hydrophobic active ingredients.
Regulating regenerative medicines – 8-Feb-2010
Stem cell research is advancing rapidly, but the lag in regulations is hindering commercial gain. Dr Paul Tomlins, National Physical Laboratory and Dr Michael Messenger, Leeds Teaching Hospitals NHS Trust/ University of Leeds, argue the new standards can help
Data handling made easy – 8-Feb-2010
Advanced data analysis software is helping researchers to find alternatives to animal testing for allergen studies, as Carl-Johan Ivarsson from Qlucore, explains
Molecules to treat MS – 11-Oct-2009
First described in 1868, multiple sclerosis is a debilitating disease that still has scientists baffled. Only now are we getting to grips with its method of attack and Dr Sarah Houlton reviews the latest drugs offering some alleviation
Fast track to tag-free proteins – 10-Sep-2009
Protein fusion technology using affinity tags has greatly simplified the process of purifying recombinant proteins. Now a single-step technology from Bio-Rad addresses the bottleneck in the subsequent tag removal process
Events
Next-generation sequencing data management – 10-Mar-2010
27 - 29 September 2010
Rhode Island Convention Centre, Providence, RI, US
Packaging Valley Days 2010 – 4-Mar-2010
9 - 10 June 2010
Schwaebisch Hall, Germany
Organic Process Research & Development – 3-Mar-2010
13 - 15 September 2010
Barcelona, Spain
Pharmacokinetics – 24-Feb-2010
9 - 10 March 2010
Philadelphia, Pennsylvania, US
Monitoring Clinical Drug Studies: Advanced – 24-Feb-2010
16-17 March 2010
San Francisco, California, US
World Pharmaceutical Congress – 24-Feb-2010
15 - 17 June 2010
Sheraton Philadelphia City Center, Philadelphia, Pennsylvania, US
Modern Synthetic Methods & Chiral Europe – 23-Feb-2010
30 June 2010 - 2 July 2010
The Mövenpick Hotel, Prague, Czech Republic
Pharma ChemOutsourcing – 22-Feb-2010
14 - 16 September 2010
Ocean Place Resort - Long Branch, NJ
XGen Congress – 11-Feb-2010
15 - 19 March 2010
San Diego, California, US
Sixth Annual PEGS Summit
The essential protein engineering summit
– 11-Feb-2010
17 - 21 May 2010
Boston, Massachusetts, US
Epilepsy: An Overview – 11-Feb-2010
5 - 6 May 2010
Central London, UK
Clinical Drug Development – 11-Feb-2010
25-26 March 2010
Philadelphia, Pennsylvania, US
The Synthetic Biology in Pharma conference – 9-Feb-2010
30 - 31 March 2010
The Wellcome Trust Conference Centre, Cambridge, UK
The Peptide Conference 2010 – 9-Feb-2010
30 - 31 March 2010
The Wellcome Trust Conference Centre, Cambridge, UK
BioFine Europe 2010 – 9-Feb-2010
30 - 31 March
The Wellcome Trust Conference Centre, Cambridge, UK
Drug Discovery Chemistry – 1-Feb-2010
27 - 29 April 2010
Hilton San Diego Resort, San Diego, California, US
The Bioprocessing Summit – 1-Feb-2010
23 - 26 August 2010
Boston Marriott Long Wharf Hotel, Boston, Massachusetts, US
Translational Regenerative Medicine – 22-Jan-2010
30 - 31 March 2010
BSG House, London, UK
Achema Asia – 20-Jan-2010
1 - 4 June 2010
Beijing, People's Republic of China
Jobs & People
Almac wins Aer Lingus Viscount award for Overall Excellence – 9-Mar-2010
Almac is recognised for its contribution to sustaining business ties between the UK and Ireland.
Genzyme funds MS academic post at Cambridge University – 5-Mar-2010
Genzyme has made a US$6m gift that will fund a key clinical academic post at Cambridge University.
BBSRC announces finalists for £20,000 bioscience prize – 23-Feb-2010
The UK’s Biotechnology and Biological Sciences Research Council has revealed the finalists in the 2010 Innovator of the Year Award competition.
Revah joins Généthon as ceo – 23-Feb-2010
Généthon, a biotherapy research centre created by the French Muscular Dystrophy Association (AFM), has appointed Frédéric Revah as chief executive.
Novavax elects Stanley Erck as executive chairman – 19-Feb-2010
The board of directors of Novavax, a US clinical-stage biotechnology firm, has elected Stanley Erck as executive chairman.